Human isotope fractional absorption studies comparing chelated Magnesium Glycinate vs. Citrate vs. 4% Oxide, CYP2R1/CYP27B1 magnesium-dependent Vitamin D3 activation trials, and Metformin-induced Vitamin B12 holotranscobalamin depletion. Explore 4,327 indexed studies and multi-trial syntheses with verified PubMed PMIDs, participant sample sizes (N), and Absolute vs. Relative Risk numbers.
The Plain-English Receipt: Only 1.2% of prediabetic adults on Tirzepatide progressed to Type 2 diabetes over 3.4 years vs. 19.3% on placebo (Absolute Risk Reduction = 18.1% • Number Needed to Treat = 6).
Both groups of salbutamol recipients showed significant improvement regarding breathing rate, TTN clinical score, and oxygenation indices compared with the placebo ( p -values Conclusion: The newly applied single high dose of...
Our findings highlight the diverse prognostic influence of genetic aberrations depending on the IGHV status in symptomatic CLL patients receiving first-line CIT.
E4/DRSP starters experienced significant improvements in the domains Pain, Water Retention and Negative Affect particularly benefiting those with more severe baseline symptoms.
Our findings do not support a relationship between testosterone replacement therapy and heart and blood vessel/cerebrovascular events in the short-to-medium term.
Vaccine receipt, female sex at birth, older age, and region may affect reactogenicity.
There was high acceptance of ATSB stations during the trial in Western Zambia.
Combined use of benazepril and amlodipine remains superior to benazepril and hydrochlorothiazide for heart and blood vessel outcomes, regardless of the magnitude of the decline in eGFR that occurred with initiation of therapy.
Cariprazine demonstrated specific antihostility/irritability and anti-agitation effects in patients with manic/mixed episodes of bipolar I disorder and baseline hostility, irritability, or agitation.
In people with HIV-1 and hepatitis B virus treated with first-line B/F/TAF or DTG + F/TDF, preexisting HIV-1 resistance was uncommon and did not affect virologic suppression.
IRd may be particularly beneficial in patients with ≥2 prior lines of therapy (IPCW and MSM HR=0.52, 95% CI: 0.30-0.88; RPSFTM HR=0.68, 95% CI: 0.51-0.91).
This study showed that bio-etanercept was equivalent to the reference formulation.
CAB + RPV LA was efficacious and well tolerated, regardless of baseline BMI category.
HAI titers partially mediate influenza vaccine efficacy against influenza A(H1N1), A(H3N2), and B/Victoria.
Rapid analysis in applied healthcare research can produce timely and trustworthy findings.
Our findings suggest that radiological CR at first disease re-evaluation is associated with more prolonged survival; this might result from stronger dependence on HER2 pathway addiction, supporting the need for further...
Among 494 included patients, 145 (29.4%) had died at three months and 344 (69.6%) had severe chemotherapy toxicity.
A 1-week HGNS therapy withdrawal period impacted OSA-related sleep symptoms.
Considerably, higher endocan levels in patients with OSA in comparison with non-OSA individuals might have clinical implications.
These findings further support the benefits of tezepelumab in patients with severe, uncontrolled asthma and can help to inform healthcare providers' treatment decisions.
Notably, hetrombopag yielded high response rates, even among patients who had previously shown limited response to eltrombopag.
The addition of atorvastatin to metformin improved HbA1c and LDL-C levels to a significant extent compared to metformin or atorvastatin alone in diabetes and high cholesterol patients.
Relative changes in FeNO and Eos were not associated with AER, regardless of treatment arm.
Semaglutide 2.4 mg significantly improved physical functioning, with greater proportions of participants achieving MWPC compared with placebo, and showed beneficial effects on WRQOL and HRQOL beyond physical functioning.
This systematic review and meta-analysis showed a high prevalence of some sleep problems, mainly obstructive sleep apnea, poor sleep quality, and other sleep problems.
Despite higher age and more advanced disease in ATOS, outcome was similar to the ATLG arm of our RCT.
Improved sleep with foslevodopa/foscarbidopa was associated with improved QoL and "Off" time.
Consistency of the MIDD approach with observed clinical outcomes confirmed the hypothesis that lower C trough did not lead to increased relapse rates at the doses administered.
Our results indicate that more intensive BP control is associated with a reduction in heart and blood vessel morbidity and mortality in patients with hypertensive PAD.
A total of 28 trials with 23,622 participants (44.2% female) were included.
Protein levels of VEGF-A, angiopoietin-2 and rs6770663 in KCNAB1 are independent risk factors and, when combined, may improve prediction of bevacizumab-induced high blood pressure.
Traditional health headlines often exaggerate findings by reporting only Relative Risk Reduction—for example, claiming a drug cuts risk by 50% when the event rate dropped from 2% to 1% (an Absolute Risk Reduction of just 1.0 percentage point, meaning 100 patients must take the drug for 1 person to benefit, or NNT = 100). On dotMD, every flagship study breakdown reports both Relative Risk and Absolute Risk alongside the exact sample size (N) and trial duration.
Every study on dotMD displays its exact Study Design Tier at the top of the card (Phase 3 Randomized Trial, Randomized Controlled Trial, Meta-Analysis & Systematic Review, Multi-Trial Clinical Evidence Synthesis, Journal Watch Cohort, or FDA Safety Alert) along with the human participant count (N). Preclinical mouse or cell-culture data is never presented as human clinical proof.
Arbitrary 0-to-100 rigor scores obscure what actually makes a study trustworthy. Instead of synthetic scores, dotMD surfaces the verifiable primary evidence signals: exact NCBI PubMed IDs (PMID), ClinicalTrials.gov registration numbers (NCT), double-blind vs. crossover design, sample size (N), p-values / Hazard Ratios, and study limitations.
Medical research is only useful if you can act on it safely with your clinician. Every flagship research synthesis links directly to the parent Condition diagnostic cutoff guide, the Medication FDA DailyMed & CMS NADAC wholesale price ledger, the Supplement elemental weight decoder, and our High-CPT-Volume Specialist Directory.
